Post-treatment monitoring of salivary gland cancer: REFCOR recommendations by the formal consensus method.

IF 16.4 1区化学 Q1 CHEMISTRY, MULTIDISCIPLINARY

Accounts of Chemical Research Pub Date : 2024-11-01 Epub Date: 2023-11-28 DOI:10.1016/j.anorl.2023.11.003

E Chabrillac, S Vergez, B Barry, F Jegoux, B Verillaud, N Pham Dang, B Baujat, N Fakhry

{"title":"Post-treatment monitoring of salivary gland cancer: REFCOR recommendations by the formal consensus method.","authors":"E Chabrillac, S Vergez, B Barry, F Jegoux, B Verillaud, N Pham Dang, B Baujat, N Fakhry","doi":"10.1016/j.anorl.2023.11.003","DOIUrl":null,"url":null,"abstract":"Objective: To determine the frequency and modality of post-treatment monitoring of primary salivary gland cancer.Material and methods: The French Network of Rare Head and Neck Tumors (REFCOR) formed a steering group who drafted a narrative review of the literature published on Medline and proposed recommendations. The level of adherence to the recommendations was then assessed by a rating group, according to the formal consensus method.Results: Clinical monitoring should be adapted to the risk of recurrence: initially every 3 months and progressively spaced out, becoming annual after 5 years. Post-treatment head and neck and chest imaging is recommended at 3 months. Local and regional monitoring can then be carried out yearly or twice yearly with contrast-enhanced head and neck imaging. An annual chest CT scan is recommended for high-grade tumors. For lesions at high risk of late recurrence, very prolonged annual surveillance (up to 15 years) is recommended, including screening for pulmonary metastases.Conclusion: Given the wide range of malignant salivary gland tumors, the modalities and frequency of post-treatment monitoring must be adapted to the expected course of the disease.","PeriodicalId":1,"journal":{"name":"Accounts of Chemical Research","volume":null,"pages":null},"PeriodicalIF":16.4000,"publicationDate":"2024-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Accounts of Chemical Research","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1016/j.anorl.2023.11.003","RegionNum":1,"RegionCategory":"化学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2023/11/28 0:00:00","PubModel":"Epub","JCR":"Q1","JCRName":"CHEMISTRY, MULTIDISCIPLINARY","Score":null,"Total":0}

引用次数: 0

Abstract

Objective: To determine the frequency and modality of post-treatment monitoring of primary salivary gland cancer.

Material and methods: The French Network of Rare Head and Neck Tumors (REFCOR) formed a steering group who drafted a narrative review of the literature published on Medline and proposed recommendations. The level of adherence to the recommendations was then assessed by a rating group, according to the formal consensus method.

Results: Clinical monitoring should be adapted to the risk of recurrence: initially every 3 months and progressively spaced out, becoming annual after 5 years. Post-treatment head and neck and chest imaging is recommended at 3 months. Local and regional monitoring can then be carried out yearly or twice yearly with contrast-enhanced head and neck imaging. An annual chest CT scan is recommended for high-grade tumors. For lesions at high risk of late recurrence, very prolonged annual surveillance (up to 15 years) is recommended, including screening for pulmonary metastases.

Conclusion: Given the wide range of malignant salivary gland tumors, the modalities and frequency of post-treatment monitoring must be adapted to the expected course of the disease.

查看原文本刊更多论文

唾液腺癌治疗后监测:REFCOR推荐的正式共识方法。

目的:探讨原发性唾液腺癌术后监测的频率和方式。材料和方法:法国罕见头颈部肿瘤网络(REFCOR)成立了一个指导小组，起草了Medline上发表的文献的叙述性综述，并提出了建议。然后，根据正式的共识方法，由一个评级小组评估对建议的遵守程度。结果:临床监测应适应复发风险:最初每3个月一次，逐渐间隔，5年后改为每年一次。治疗后建议在3个月时进行头颈部和胸部影像学检查。然后可以每年或每年两次使用对比度增强的头颈部成像进行局部和区域监测。对于恶性肿瘤，建议每年做一次胸部CT扫描。对于晚期复发风险高的病变，建议延长年度监测时间(长达15年)，包括肺转移筛查。结论:恶性唾液腺肿瘤的范围广泛，治疗后监测的方式和频率必须与疾病的预期病程相适应。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Accounts of Chemical Research 化学-化学综合

CiteScore

31.40

自引率

1.10%

发文量

312

审稿时长

2 months

期刊介绍： Accounts of Chemical Research presents short, concise and critical articles offering easy-to-read overviews of basic research and applications in all areas of chemistry and biochemistry. These short reviews focus on research from the author’s own laboratory and are designed to teach the reader about a research project. In addition, Accounts of Chemical Research publishes commentaries that give an informed opinion on a current research problem. Special Issues online are devoted to a single topic of unusual activity and significance. Accounts of Chemical Research replaces the traditional article abstract with an article "Conspectus." These entries synopsize the research affording the reader a closer look at the content and significance of an article. Through this provision of a more detailed description of the article contents, the Conspectus enhances the article's discoverability by search engines and the exposure for the research.